News Room

Odds are that you’re going to be more likely to deal with haters than fans on a Facebook page, according to a recent study. But smart moderation tactics can help defuse issues before they get out of hand.

The promise of artificial intelligence (AI) improving our lives is enormous. In less than a quarter of a century, the Internet has grown from niche curiosity to a modern necessity for much of the world. Interpersonal communication has never been easier and social media has profoundly changed how people interact. This same technology that allows for a more efficient and communicative modern life also puts public and personal information at risk and creates new anxieties among the public and policymakers. These heightened concerns should not be a hinderance to the furtherance of technology, but rather, they should serve as a catalyst for necessary reflection and planning. To fully realize the benefits of these technologies, organizational goals must align with defined ethical values and the public interest.

From Sephora to Amazon to Dominos Pizza – major companies have employed chatbots to interact with millions of customers from around the world.

These artificial intelligent systems have been found to outsell human employees by four times and at almost zero marginal costs.

E-commerce brands’ business models are getting more interesting. If you are an investor, these are fundable businesses. The most popular models are direct-to-consumer brands like Warby Parker or Casper; subscription companies like Blue Apron; experiential commerce companies and food delivery companies like Uber Eats.

Adults with diabetes have a two- to three-times increased risk of early death compared to individuals without diabetes. Leaving diabetes uncontrolled can damage the kidneys, eyes, nerves and heart. Our new study published in JAMA Internal Medicine found that less than one in four American adults diagnosed with diabetes reach the care targets recommended by the American Diabetes Association. Moreover, efforts to reach care targets have not made headway since 2005 — these are startling statistics.